Trends in implantable cardioverter-defibrillator programming practices and its impact on therapies: Insights from a North American Remote Monitoring Registry 2007–2018

Abstract

This is a PDF file of an article that has undergone enhancements after acceptance, such as the addition of a cover page and metadata, and formatting for readability, but it is not yet the definitive version of record. This version will undergo additional copyediting, typesetting and review before it is published in its final form, but we are providing this version to give early visibility of the article. Please note that, during the production process, errors may be discovered which could affect the content, and all legal disclaimers that apply to the journal pertain.

Primary prevention programming for defibrillators: need for a device clinic-based intervention

“…What strategies are most likely to improve guideline concordant programming across the spectrum of EP centers? This clearly should be high priority issue within the EP community, as this is a relatively low-effort intervention that is directly linked to better patient outcomes [8,9]. An obvious solution would be for the major device manufacturers to have their specified primary prevention programming as the outof-the-box nominal setting.…”